Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Bipolar Disorder I”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01058096
What this trial is testing

Safety and Efficacy of Cariprazine for Mania

Who this might be right for
Bipolar DisorderMania
Forest Laboratories 323
Large-scale testing (Phase 3)Study completedNCT00227305
What this trial is testing

Quetiapine Fumarate (SEROQUEL) in the Treatment of Adolescent Patients With Schizophrenia and Bipolar I Disorder

Who this might be right for
SchizophreniaBipolar I Disorder
AstraZeneca 381
Large-scale testing (Phase 3)Study completedNCT01284517
What this trial is testing

Lurasidone HCI - A 6-week Phase 3 Study of Patients With Bipolar I Depression

Who this might be right for
Bipolar Depression
Sumitomo Pharma America, Inc. 356
Post-approval studies (Phase 4)Study completedNCT00034580
What this trial is testing

Olanzapine Versus Active Comparator in the Treatment of Bipolar I Disorder

Who this might be right for
Bipolar Disorder
Eli Lilly and Company 326
Large-scale testing (Phase 3)Study completedNCT01396291
What this trial is testing

Efficacy and Safety of Asenapine in the Prevention of Recurrence of Mood Episodes in Participants With Bipolar 1 Disorder (P06384)

Who this might be right for
Bipolar 1 Disorder
Forest Laboratories 561
Not applicableUnknownNCT05249309
What this trial is testing

Naturalistic Study of Ketamine in the Treatment of Depression

Who this might be right for
Major Depressive DisorderBipolar DisorderBipolar Depression+3 more
Hospital de Clinicas de Porto Alegre 90
Post-approval studies (Phase 4)Study completedNCT00188643
What this trial is testing

Venlafaxine Versus Lamotrigine in the Treatment of Bipolar I/II Depression

Who this might be right for
Bipolar Disorder
University Health Network, Toronto 40
Large-scale testing (Phase 3)Looking for participantsNCT06372964
What this trial is testing

Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients

Who this might be right for
Bipolar Depression
Intra-Cellular Therapies, Inc. 384
Testing effectiveness (Phase 2)Looking for participantsNCT07540338
What this trial is testing

Investigate Lithium Brain/Plasma Pharmacokinetics and Safety of an AL001 Oral Capsule Compared to a Marketed Immediate-release Lithium Carbonate Capsule in Subjects With Bipolar I Disorder

Who this might be right for
Bipolar I Disorder
Alzamend Neuro, Inc. 20
Large-scale testing (Phase 3)Study completedNCT01710709
What this trial is testing

Open-label Study to Evaluate the Effectiveness of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients With Bipolar I Disorder

Who this might be right for
Bipolar I
Otsuka Pharmaceutical Development & Commercialization, Inc. 748
Post-approval studies (Phase 4)Study completedNCT00463580
What this trial is testing

Infliximab for Treatment Resistant Major Depression

Who this might be right for
Depression
Emory University 60
Large-scale testing (Phase 3)Study completedNCT00094432
What this trial is testing

Aripiprazole in Patients With Bipolar I Disorder With a Major Depressive Episode

Who this might be right for
Bipolar I Disorder
Otsuka Pharmaceutical Development & Commercialization, Inc. 650
Testing effectiveness (Phase 2)Study completedNCT00141505
What this trial is testing

PK Effects of Bifeprunox & Valproate in Bipolar I

Who this might be right for
Bipolar I Disorder
Solvay Pharmaceuticals
Testing effectiveness (Phase 2)Looking for participantsNCT07494305
What this trial is testing

Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE.

Who this might be right for
Bipolar I Disorder
LB Pharmaceuticals Inc. 320
Large-scale testing (Phase 3)Study completedNCT03287869
What this trial is testing

A Trial to Evaluate the Safety and Tolerability of Brexpiprazole in the Treatment of Participants With Bipolar I Disorder.

Who this might be right for
Bipolar I DisorderAcute Mania
Otsuka Pharmaceutical Development & Commercialization, Inc. 381
Large-scale testing (Phase 3)Study completedNCT00083954
What this trial is testing

Controlled Study of the Use of Quetiapine Fumarate in the Treatment of Patients With Bipolar Depression

Who this might be right for
Bipolar Disorder
AstraZeneca 530
Not applicableStudy completedNCT01841970
What this trial is testing

Safety and Efficacy Study of HET Bipolar System for Treatment of Stage I and Stage II Hemorrhoids

Who this might be right for
Hemorrhoids, Internal
Medtronic - MITG 20
Not applicableStudy completedNCT05870501
What this trial is testing

Synaptic Imaging and Network Activity in Treatment Resistant Depression

Who this might be right for
Depressive DisorderDepressive Disorder, MajorDepressive Disorder, Treatment-Resistant+5 more
King's College London 56
Not applicableNot Yet RecruitingNCT07101107
What this trial is testing

Socio-cognitive and Biological Responses to Maltreatment

Who this might be right for
Bipolar 1 DisorderControl Subjects
Medical University Innsbruck 160
Large-scale testing (Phase 3)Study completedNCT00606177
What this trial is testing

A Multicenter, Placebo-controlled, Double-blind Investigative Extension Trial of the Safety and Efficacy of Aripiprazole in the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode

Who this might be right for
Bipolar I Disorder
Otsuka Pharmaceutical Co., Ltd. 99
Next Page